JPMorgan Chase & Co’s Silence Therapeutics SLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42.2K | Sell |
7,283
-28,131
| -79% | -$163K | ﹤0.01% | 5150 |
|
|
2025
Q1 | $99.9K | Buy |
35,414
+31,621
| +834% | +$89.2K | ﹤0.01% | 4738 |
|
|
2024
Q4 | $26.1K | Buy |
+3,793
| New | +$26.1K | ﹤0.01% | 5171 |
|
|
2024
Q2 | – | Sell |
-9,610
| Closed | -$208K | – | 6535 |
|
|
2024
Q1 | $208K | Buy |
+9,610
| New | +$208K | ﹤0.01% | 4431 |
|
|
2022
Q1 | – | Sell |
-6,730
| Closed | -$157K | – | 5922 |
|
|
2021
Q4 | $157K | Buy |
+6,730
| New | +$157K | ﹤0.01% | 4652 |
|